⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for adult anaplastic meningioma

Every month we try and update this database with for adult anaplastic meningioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain TumorsNCT00499798
Brain and Centr...
Chemotherapeuti...
Infertility
18 Years - 60 YearsWake Forest University Health Sciences
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain TumorsNCT00002647
Brain and Centr...
Metastatic Canc...
verteporfin
conventional su...
3 Years - 70 YearsNational Cancer Institute (NCI)
Vatalanib in Treating Patients With Recurrent or Progressive MeningiomaNCT00348790
Brain and Centr...
Sarcoma
vatalanib
18 Years - Northwestern University
Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2NCT01082926
Anaplastic Astr...
Anaplastic Epen...
Anaplastic Meni...
Anaplastic Olig...
Brain Stem Glio...
Ependymoblastom...
Giant Cell Glio...
Glioblastoma
Gliosarcoma
Grade III Menin...
Meningeal Heman...
Mixed Glioma
Pineal Gland As...
Brain Tumor
therapeutic all...
aldesleukin
laboratory biom...
positron emissi...
18 Years - 70 YearsCity of Hope Medical Center
Study of Tissue Samples From Patients With Glioma or Other Brain TumorsNCT00967200
Central Nervous...
laboratory biom...
pharmacogenomic...
18 Years - 120 YearsUniversity Hospital, Montpellier
Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III MeningiomaNCT00895622
Brain and Centr...
54 Gy radiother...
60 Gy radiother...
18 Years - Radiation Therapy Oncology Group
Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive MeningiomaNCT00904735
Brain and Centr...
hydroxyurea
imatinib mesyla...
18 Years - 75 YearsNational Cancer Institute (NCI)
Vatalanib in Treating Patients With Recurrent or Progressive MeningiomaNCT00348790
Brain and Centr...
Sarcoma
vatalanib
18 Years - Northwestern University
Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive MeningiomaNCT00904735
Brain and Centr...
hydroxyurea
imatinib mesyla...
18 Years - 75 YearsNational Cancer Institute (NCI)
Bevacizumab in Treating Patients With Recurrent or Progressive MeningiomasNCT01125046
Acoustic Schwan...
Adult Anaplasti...
Adult Ependymom...
Adult Grade I M...
Adult Grade II ...
Adult Meningeal...
Adult Papillary...
Neurofibromatos...
Neurofibromatos...
Recurrent Adult...
bevacizumab
18 Years - Northwestern University
Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family CaregiversNCT00376818
Brain and Centr...
Psychosocial Ef...
exercise interv...
educational int...
physiologic tes...
management of t...
mind-body inter...
Measurement of ...
18 Years - Case Comprehensive Cancer Center
Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain DisordersNCT00255671
Brain and Centr...
Metastatic Canc...
Radiation Toxic...
Questionnaire
18 Years - Case Comprehensive Cancer Center
Bevacizumab in Treating Patients With Recurrent or Progressive MeningiomasNCT01125046
Acoustic Schwan...
Adult Anaplasti...
Adult Ependymom...
Adult Grade I M...
Adult Grade II ...
Adult Meningeal...
Adult Papillary...
Neurofibromatos...
Neurofibromatos...
Recurrent Adult...
bevacizumab
18 Years - Northwestern University
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain TumorsNCT00629889
Brain and Centr...
Seizure
levetiracetam
pregabalin
18 Years - Centre Hospitalier Universitaire Vaudois
Yoga Therapy in Treating Patients With Malignant Brain TumorsNCT01234805
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Choroid P...
Adult Diffuse A...
Adult Ependymob...
Adult Ependymom...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Grade II ...
Adult Medullobl...
Adult Meningeal...
Adult Mixed Gli...
Adult Oligodend...
Adult Papillary...
Adult Pineal Gl...
Adult Pineoblas...
Adult Pineocyto...
Adult Supratent...
Recurrent Adult...
yoga therapy
questionnaire a...
quality-of-life...
18 Years - Wake Forest University Health Sciences
Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to TreatmentNCT00544284
Brain and Centr...
Lymphoma
Metastatic Canc...
Unspecified Adu...
bortezomib
temozolomide
pharmacological...
18 Years - City of Hope Medical Center
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain TumorsNCT02194452
Acoustic Schwan...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Choroid P...
Adult Craniopha...
Adult Diffuse A...
Adult Ependymob...
Adult Ependymom...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Grade I M...
Adult Grade II ...
Adult Medullobl...
Adult Meningeal...
Adult Mixed Gli...
Adult Myxopapil...
Adult Oligodend...
Adult Papillary...
Adult Pilocytic...
Adult Pineal Gl...
Adult Pineoblas...
Adult Pineocyto...
Adult Subependy...
Adult Subependy...
Adult Supratent...
Childhood Choro...
Childhood Crani...
Childhood Epend...
Childhood Grade...
Childhood Grade...
Childhood Grade...
Childhood High-...
Childhood High-...
Childhood Infra...
Childhood Low-g...
Childhood Low-g...
Childhood Medul...
Childhood Supra...
Meningeal Melan...
Newly Diagnosed...
Recurrent Adult...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
gallium Ga 68-e...
positron emissi...
computed tomogr...
laboratory biom...
6 Months - 29 YearsUniversity of Iowa
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerNCT00492089
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Central N...
Adult Choroid P...
Adult Diffuse A...
Adult Ependymom...
Adult Grade II ...
Adult Grade III...
Adult Malignant...
Adult Mixed Gli...
Adult Oligodend...
Adult Papillary...
Adult Pineocyto...
Malignant Neopl...
Meningeal Melan...
Radiation Toxic...
Recurrent Adeno...
Recurrent Adult...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Esthesi...
Stage I Inverte...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Midline...
Stage I Mucoepi...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage III Adeno...
Stage III Basal...
Stage III Esthe...
Stage III Inver...
Stage III Lymph...
Stage III Midli...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
bevacizumab
placebo
magnetic resona...
quality-of-life...
18 Years - National Cancer Institute (NCI)
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain TumorsNCT00629889
Brain and Centr...
Seizure
levetiracetam
pregabalin
18 Years - Centre Hospitalier Universitaire Vaudois
Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive MeningiomaNCT00354913
Glioblastoma
Gliosarcoma
hydroxyurea
imatinib mesyla...
18 Years - Duke University
Bevacizumab in Treating Patients With Recurrent or Progressive MeningiomasNCT01125046
Acoustic Schwan...
Adult Anaplasti...
Adult Ependymom...
Adult Grade I M...
Adult Grade II ...
Adult Meningeal...
Adult Papillary...
Neurofibromatos...
Neurofibromatos...
Recurrent Adult...
bevacizumab
18 Years - Northwestern University
Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III MeningiomaNCT00895622
Brain and Centr...
54 Gy radiother...
60 Gy radiother...
18 Years - Radiation Therapy Oncology Group
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerNCT00492089
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Central N...
Adult Choroid P...
Adult Diffuse A...
Adult Ependymom...
Adult Grade II ...
Adult Grade III...
Adult Malignant...
Adult Mixed Gli...
Adult Oligodend...
Adult Papillary...
Adult Pineocyto...
Malignant Neopl...
Meningeal Melan...
Radiation Toxic...
Recurrent Adeno...
Recurrent Adult...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Esthesi...
Stage I Inverte...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Midline...
Stage I Mucoepi...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage III Adeno...
Stage III Basal...
Stage III Esthe...
Stage III Inver...
Stage III Lymph...
Stage III Midli...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
bevacizumab
placebo
magnetic resona...
quality-of-life...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: